Clinical Trials Browser

INDUSTRY × Skin Neoplasms × Dacarbazine × Clear all

NCT01763164 2021-03-22

Study Comparing the Efficacy of MEK162 Versus Dacarbazine in Unresectable or Metastatic NRAS Mutation-positive Melanoma

Phase 3 Completed

402 enrolled 21 charts

Melanoma, Neoplasm Metastasis, Skin Diseases, Skin Neoplasms

NCT00518895 2011-11-07

AGENDA

Phase 3 Completed

Melanoma, Skin Neoplasms

NCT00070642 2009-02-10

CPG 7909 Injection in Melanoma

Phase 2 Completed

Carcinoma, Melanoma, Skin Neoplasms

NCT00003647 2008-07-25

Chemotherapy With or Without Immunotherapy in Treating Patients With Stage III or Stage IV Melanoma

Phase 3 Completed

Melanoma, Neoplasms, Skin Neoplasms